GLP-1 RAs Linked to Higher Hair Loss Risk - Takeaways - MDSpire

GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

  • By

  • Kerri Miller

  • February 19, 2026

  • 3 min

Share

  • 1

    GLP-1 receptor agonists (RAs) are linked to higher odds of nonscarring hair loss in adults compared to matched controls.

  • 2

    At 6 months, GLP-1 RA users had 1.62 times the odds of androgenetic alopecia and 1.26 times the odds of overall nonscarring hair loss.

  • 3

    By 12 months, the odds increased to 1.76 for telogen effluvium, 1.64 for androgenetic alopecia, and 1.40 for overall nonscarring hair loss.

  • 4

    The study highlights a rising incidence of nonscarring hair loss among GLP-1 RA users from 2014 to 2024, diverging trends noted from 2019.

  • 5

    Researchers emphasize the need for awareness of alopecia risk in GLP-1 RA patients for early detection and call for further research.

Original Source(s)

GLP-1 RAs Linked to Higher Hair Loss Risk

  • by Kerri Miller

  • February 19, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Bad Hair Day

Non-targeted mass spectrometry finds chemicals linked to cancer and hormone disruption in hair extensions 

  • March 3, 2026

  • 2 min
Unexpected Finds After Routine Procedures

Two patients presented months after minimally invasive facial procedures with persistent findings that ultimately revealed retained foreign bodies, according to a recent case series.